top of page

PARTNERSHIPS

We believe in the power of partnerships. We believe that collaboration is key to accelerating the development of innovative and life-saving therapies. Through partnerships, collaboration and strategic alliances we are developing safe and effective therapies for some of the most debilitating diseases. Leveraging our library of novel and First-in-Class of Peptide Conjugate Nanosystems (PCN)TM and innovative proprietary technology platforms we are developing novel therapies for central nervous system diseases and other disorders by delivering next generation and precision advanced therapies.

​

Scientist on Computer

Science

Learn more about our Therapeutic Platforms

Scientist

Partners

We are partnering with researchers from across the world to find safe and effective therapies for debilitating diseases.

DELIVERING LIFE SAVING THERAPIES,

OVERCOMING BARRIERS

Our approach is different. We have designed and optimised effective and versatile delivery platform technologies along with a library of new class of nanoparticles. We have also focused on designing the next generation therapeutics expanding our discovery Programmes.

If you are interested in partnering with us to deliver the next generation of 21st century therapies, contact us today.

SMDG collaborates with researchers at companies, universities and non- profit organisations on innovative and therapeutic projects.
bottom of page